AXIM Biotechnologies (AXIM) News Today → Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad) Free AXIM Stock Alerts $0.01 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 11, 2024 | morningstar.comAXIM Biotechnologies Inc AXIMApril 18, 2024 | seekingalpha.comADPT Adaptive Biotechnologies CorporationApril 4, 2024 | msn.comAxim youth appeal for sports infrastructureMarch 27, 2024 | globenewswire.comVIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024March 7, 2024 | msn.comWe Want Peaceful Elections – Axim YouthFebruary 20, 2024 | finance.yahoo.comAXIM® Biotechnologies’ Tear Based Testing Platform Continues to Gain Traction After Successful Clinical ValidationFebruary 20, 2024 | globenewswire.comAXIM® Biotechnologies' Tear Based Testing Platform Continues to Gain Traction After Successful Clinical ValidationFebruary 7, 2024 | msn.comAxim Fishermen Hail GovtFebruary 6, 2024 | msn.comMASLOC Trial: Daniel Axim Denies ChargesDecember 21, 2023 | msn.comAXIM and Auer partner for dry eye disease assay productionDecember 20, 2023 | finance.yahoo.comAXIM® Biotechnologies Partners With Leading Diagnostic Manufacturer Auer Precision to Scale Assay ProductionDecember 11, 2023 | msn.comTullow builds 14-unit dormitory block for Axim Girls SHSDecember 2, 2023 | seekingalpha.comLLBO Lifeline Biotechnologies, Inc.December 2, 2023 | seekingalpha.comCollPlant Biotechnologies Ltd. (CLGN) Q3 2023 Earnings Call TranscriptNovember 8, 2023 | msn.comCourt Orders Mental Test For Axim In MASLOC TrialNovember 1, 2023 | msn.comAxim Fishermen Plead For More PremixSeptember 12, 2023 | stockhouse.comAXIM® Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson's DiseaseSeptember 12, 2023 | finance.yahoo.comAXIM® Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson’s DiseaseSeptember 10, 2023 | finance.yahoo.comAXIM - AXIM Biotechnologies, Inc.August 1, 2023 | finance.yahoo.comAXIM® Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its Rapid Point of Care Neutralizing Antibody TestJuly 12, 2023 | finance.yahoo.comUpdate: AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers NationwideJuly 12, 2023 | finance.yahoo.comUpdate: AXIM Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers NationwideJuly 12, 2023 | finance.yahoo.comAXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers NationwideJune 14, 2023 | markets.businessinsider.comNV5's Newly Acquired Subsidiary Axim Pockets Contract From National Geospatial Intelligence AgencyMay 24, 2023 | finance.yahoo.comAXIM Biotechnologies Announces Over 40 Initial Clinic Commitments for Its Full Diagnostic Assay Platform LaunchMay 23, 2023 | finance.yahoo.comAXIM® Biotechnologies Appoints Kurt Phinney as Chief Operating Officer to Drive Scaling and Optimization of Manufacturing UnitMay 20, 2023 | businesswire.comiXCells Biotechnologies Expands CRISPR-Cas9 Cell Products and Genome Engineering ServicesMay 16, 2023 | marketwatch.comVitiligo Drug Market Analysis and Growth Foresights till 2031April 23, 2023 | msn.comAxim Galamsey Gang Prime Suspect ArrestedApril 11, 2023 | finance.yahoo.comAXIM® Biotechnologies Commences Commercial Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic AssaysApril 7, 2023 | msn.comNzema East MCE assures public of peace, tranquility in AximMarch 31, 2023 | seekingalpha.comCollPlant Biotechnologies Ltd. (CLGN) Q4 2022 Earnings Call TranscriptMarch 30, 2023 | technews.tmcnet.comIntroducing Axim Collaborative and the Appointment of Stephanie Khurana as Chief Executive OfficerMarch 29, 2023 | msn.comAxim Tartan Tracks ReadyMarch 29, 2023 | nasdaq.comAdaptive Biotechnologies Shares Cross Above 200 DMAMarch 22, 2023 | msn.comAxim Youth Centre Almost CompleteMarch 14, 2023 | finance.yahoo.comMedical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further ExpansionMarch 14, 2023 | finance.yahoo.comAXIM® Biotechnologies Files Provisional Patent on Novel Methodology for Use in Optical Diagnostic Assay ManufacturingJanuary 17, 2023 | finance.yahoo.comAXIM Biotechnologies Files Patent on Fentanyl Neutralizing Antibody Test, Applies for DEA License to Work With Controlled SubstanceJanuary 11, 2023 | finance.yahoo.comAXIM® Biotechnologies CEO Issues Letter to Shareholders; Reminds of Conference CallDecember 13, 2022 | finance.yahoo.comAXIM® Biotechnologies Develops Novel Dual IgE/MMP-9 Rapid Ophthalmological Diagnostic Test; Files Provisional PatentDecember 6, 2022 | finance.yahoo.comAXIM Biotechnologies Commercial Partner Verséa Ophthalmics Highlights Benefits of AXIM’s Eye Diagnostic SolutionsDecember 5, 2022 | msn.comChief Imam Storms Axim HometownNovember 12, 2022 | finance.yahoo.comGlobal Biotechnology / Pharmaceutical Services Outsourcing Market to Reach $86 Billion by 2027October 6, 2022 | marketwatch.comAXIM(R) Biotechnologies Receives Initial Order for Diagnostic Solutions as Exclusive Partner Versea Ophthalmics Commences Initial Commercial LaunchOctober 4, 2022 | finance.yahoo.comAXIM® Biotechnologies Receives Initial Order for Diagnostic Solutions as Exclusive Partner Verséa Ophthalmics Commences Initial Commercial LaunchSeptember 29, 2022 | finance.yahoo.comAXIM® Biotechnologies Point-of-Care Diagnostic Test Platform Sales Commence With Verséa Ophthalmics’ Commercial Launch at AAO 2022September 19, 2022 | finance.yahoo.comAXIM® Biotechnologies Signs Exclusive Global Commercialization Agreement With Verséa™ Ophthalmics for Distribution and Sales of Novel Ophthalmic Diagnostics SolutionsSeptember 12, 2022 | msn.comAxim Mini-Habour 85% CompleteSeptember 8, 2022 | finance.yahoo.comMedical Marijuana, Inc. Signs Deal With Leading European Manufacturer and Distributor to Expand Channel Access to Products Throughout the Region Get AXIM Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for AXIM and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. AXIM Media Mentions By Week AXIM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AXIM News Sentiment▼-0.500.53▲Average Medical News Sentiment AXIM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AXIM Articles This Week▼10▲AXIM Articles Average Week Get AXIM Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for AXIM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AGNPF News AKBLF News DRTSW News ARNI News ARTLW News ASCLF News AWKNF News BRRGF News BCTXW News CLVLY News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:AXIM) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThe Next Industry Being Reshaped By AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceUrgent Nvidia WarningAltimetryMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AXIM Biotechnologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
